IDEAYA Biosciences, Inc. (IDYA)

IDEAYA Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	130	84.38	157.02	68.63	92.05	72.04
Short-Term Investments	562.51	591.94	368.1	296.2	154.72	211.55
Cash & Short-Term Investments	692.51	676.32	525.11	364.83	246.77	283.59
Cash Growth	-0.90%	28.79%	43.93%	47.84%	-12.98%	186.58%
Receivables	-	0	0.02	0.21	1.1	1.88
Prepaid Expenses	15.36	13.39	7.5	5.41	3.12	3.14
Total Current Assets	707.87	689.71	532.63	370.45	251	288.61
Property, Plant & Equipment	33.3	27.74	8.41	8.99	8.66	9.48
Long-Term Investments	358.67	405.83	107.49	8.32	121.29	-
Other Long-Term Assets	0.81	0.81	0.78	0.21	0.4	0.19
Total Assets	1,101	1,124	649.32	387.97	381.35	298.27
Accounts Payable	17.63	15.42	6.6	4.28	2.1	0.95
Accrued Expenses	32.91	30.35	18.76	17	12.32	8.52
Current Portion of Leases	0.31	0.3	1.75	1.87	1.7	1.54
Current Unearned Revenue	-	-	-	8.57	29.04	27.61
Other Current Liabilities	-	-	-	-	-	0.02
Total Current Liabilities	50.85	46.07	27.1	31.72	45.16	38.64
Long-Term Leases	25.66	18.87	1.13	1.61	3.48	5.18
Long-Term Unearned Revenue	-	-	-	5.19	31.19	56.16
Other Long-Term Liabilities	-	-	-	-	-	0.01
Total Liabilities	76.51	64.94	28.23	38.51	79.83	100
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	1,718	1,681	968.89	587.72	478.97	325.25
Retained Earnings	-695.02	-622.84	-348.36	-235.4	-176.75	-126.99
Comprehensive Income & Other	1.59	0.81	0.56	-2.87	-0.71	0.01
Total Common Equity	1,024	1,059	621.09	349.46	301.51	198.27
Shareholders' Equity	1,024	1,059	621.09	349.46	301.51	198.27
Total Liabilities & Equity	1,101	1,124	649.32	387.97	381.35	298.27
Total Debt	25.97	19.17	2.87	3.48	5.18	6.72
Net Cash (Debt)	1,025	1,063	629.73	369.66	362.88	276.86
Net Cash Growth	9.18%	68.80%	70.35%	1.87%	31.07%	195.45%
Net Cash Per Share	12.06	13.01	10.95	8.92	10.29	11.20
Filing Date Shares Outstanding	87.58	87.54	74.56	48.39	38.63	32.25
Total Common Shares Outstanding	87.57	86.5	65.04	48.19	38.53	29.52
Working Capital	657.03	643.64	505.53	338.74	205.84	249.97
Book Value Per Share	11.70	12.24	9.55	7.25	7.82	6.72
Tangible Book Value	1,024	1,059	621.09	349.46	301.51	198.27
Tangible Book Value Per Share	11.70	12.24	9.55	7.25	7.82	6.72
Machinery	16	15.53	12.22	10.51	7.02	5.33
Leasehold Improvements	4.94	4.91	3.32	3.32	3.13	2.72

Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q